{"id":"W2898447893","doi":"10.1093/annonc/mdy269.181","title":"Neoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer: The phase II NeoRHEA trial","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Palbociclib; Medicine; Breast cancer; Oncology; Tamoxifen; Internal medicine; Letrozole; Estrogen receptor; Biomarker; Gene signature; Neoadjuvant therapy; Cancer; Metastatic breast cancer; Gene expression; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001120265,0.0002445835,0.0009041803,0.0002846985,0.0001684643,0.000005730304,0.0003090175,0.00009888117,0.0005477652],"category_scores_gemma":[0.0001172561,0.0001495636,0.00009029394,0.0009439753,0.001466851,0.0001144728,0.0001217828,0.0004077417,0.000004012354],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001344021,"about_ca_system_score_gemma":0.0007436508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004448839,"about_ca_topic_score_gemma":0.001335057,"domain_scores_codex":[0.9968562,0.0009549456,0.000639961,0.0004221289,0.0005527751,0.0005739563],"domain_scores_gemma":[0.996732,0.0007302902,0.0003911628,0.0005123969,0.001506612,0.000127554],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5536288,0.01158958,0.005222457,0.00001441802,0.0008733091,0.00005861751,0.00979142,0.000003767566,0.01545666,0.00009628931,0.0007026233,0.4025621],"study_design_scores_gemma":[0.4142554,0.4347134,0.05996371,0.000324189,0.00009458284,0.0001303815,0.01204046,0.00005048993,0.06762852,0.0004561147,0.01004698,0.0002958435],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9785672,0.0004478143,0.000006067199,0.01692814,0.000175148,0.003146883,0.0001104962,0.00001930672,0.0005989206],"genre_scores_gemma":[0.9979014,0.0004198443,0.000164784,0.0005539106,0.0003374919,0.0004181248,0.00001172809,0.00004090612,0.0001517974],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4231238,"threshold_uncertainty_score":0.6725343,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1473216235929842,"score_gpt":0.4926245432795133,"score_spread":0.345302919686529,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}